Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9

Clinical and Vaccine Immunology

Volumn 16, Issue 2, 2009, Pages 200-208

  Baums, Christoph Georg ^a   Kock, Christoph ^a   Beineke, Andreas ^a   Bennecke, Katharina ^a   Goethe, Ralph ^a   Schröder, Charlotte ^a   Waldmann, Karl Heinz ^a   Valentin Weigand, Peter ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; MEMBRANE PROTEIN; MURAMIDASE RELEASED PROTEIN; SEROTYPE 2 MUREIN ASSOCIATED PROTEIN FRACTION SUBUNIT VACCINE; STREPTOCOCCUS VACCINE; SURFACE ANTIGEN ONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SWINE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BACTERIAL VACCINES; OPSONIN PROTEINS; PHAGOCYTOSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SWINE; SWINE DISEASES; VACCINES, SUBUNIT;

EID: 59649090469     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00371-08     Document Type: Article

References (26)

1. Baltimore, R. S., D. L. Kasper, C. J. Baker, and D. K. Goroff. 1977. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J. Immunol. 118:673-678.
2. Baums, C. G., U. Kaim, M. Fulde, G. Ramachandran, R. Goethe, and P. Valentin-Weigand. 2006. Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect. Immun. 74:6154-6162.
3. Beineke, A., K. Bennecke, C. Neis, C. Schröder, K.-H. Waldmann, W. Baum-gartner, P. Valentin-Weigand, and C. G. Baums. 2008. Comparative evaluation of virulence and pathology of Streptococcus suis serotypes 2 and 9 in experimentally infected growers. Vet. Microbiol. 128:423-430.
4. Benga, L., R. Goethe, E. GroBe Beilage, and P. Valentin-Weigand. 2004. Immunogenicity of murein-associated proteins from temperature-stressed Streptococcus suis cultures. J. Vet. Med. B 51:272-277.
5. Chabot-Roy, G., P. Willson, M. Segura, S. Lacouture, and M. Gottschalk. 2006. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microbiol. Path. 41:21-32.
6. 5a.Council of Europe. 2005. European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, European Treaty Series no. 123. Council of Europe, Strasbourg, France. http://conventions.coe.int/Treaty/en/Treaties/Html/123.htm.
7. de Greeff, A., H. Buys, R. Verhaar, J. Dijkstra, L. van Alphen, and H. E. Smith. 2002. Contribution of fibronectin-binding protein to pathogenesis of Streptococcus suis serotype 2. Infect. Immun. 70:1319-1325.
8. Elliott, S. D., and J. Y. Tai. 1978. The type-specific polysaccharides of Streptococcus suis. J. Exp. Med. 148:1699-1704.
9. Fox, J. D., and J. F. Robyt. 1991. Miniaturization of three carbohydrate analyses using a microsample plate reader. Anal. Biochem. 195:93-96.
10. Gor, D. O., X. Ding, D. E. Briles, M. R. Jacobs, and N. S. Greenspan. 2005. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneu-moniae. Infect. Immun. 73:1304-1312.
11. Haesebrouck, F., F. Pasmans, K. Chiers, D. Maes, R. Ducatelle, and A. Decostere. 2004. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet. Microbiol. 100:255-268.
12. Higgins, R., and M. Gottschalk. 2005. Streptococcal diseases, p. 769-783. In S. D. B. E. Strax, W. L. Mengeling, and D. J. Taylor (ed.), Diseases of swine, 9th ed. Iowa State University Press, Ames.
13. Holtkamp, D., H. Rotto, and R. Garcia. 2007. Economic cost of major health challenges in large US swine production systems. Part 1. 5M Enterprises, Ltd., Sheffield, England. http://www.thepigsite.com/articles/1/pig- health/1935/economic-cost-of-major-health-challenges-in-large-us-swine- production-systemspart-1.
14. Jacobs, A., A. Van den Berg, and P. Loeffen. 1996. Protection of experimentally infected pigs by suilysin, the thiol-activated hemolysin of Streptococcus suis. Vet. Rec. 139:225-228.
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Lees, A., B. L. Nelson, and J. J. Mond. 1996. Activation of soluble polysac-charides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Vaccine 14:190-198.
17. Li, Y., M. Gottschalk, M. Esgleas, S. Lacouture, J. D. Dubreuil, P. Willson, and J. Harrel. 2007. Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin. Vaccine Immunol. 14:937-943.
18. Rabilloud, T. 1999. Silverstaining of 2-D electrophoresis gels. Methods Mol. Biol. 112:297-305.
19. Rehm, T., C. G. Baums, B. Strommenger, M. Beyerbach, P. Valentin-Weigand, and R. Goethe. 2007. Amplified fragment length polymorphism of Streptococcus suis strains correlates with their profile of virulence-associated genes and clinical background. J. Med. Microbiol. 56:102-109.
20. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Silva, L. M., C. G. Baums, T. Rehm, H. J. Wisselink, R. Goethe, and P. Valentin-Weigand. 2006. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet. Microbiol. 115:117-127.
22. Smith, H. E., M. Damman, J. van der Velde, F. Wagenaar, H. J. Wisselink, N. Stockhofe-Zurwieden, and M. A. Smits. 1999. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67:1750-1756.
23. Vecht, U., H. J. Wisselink, J. E. van Dijk, and H. E. Smith. 1992. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect. Immun. 60:550-556.
24. Wisselink, H. J., H. E. Smith, N. Stockhofe-Zurwieden, K. Peperkamp, and U. Vecht. 2000. Distribution of capsular types and production of murami-dase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet. Microbiol. 74:237-248.
25. Wisselink, H. J., U. Vecht, N. Stockhofe-Zurwieden, and H. E. Smith. 2001. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet. Rec. 148:473-477.
26. Wisselink, H. J., N. Stockhofe-Zurwieden, L. A. T. Hilgers, and H. E. Smith. 2002. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2. Vet. Microbiol. 84:155-168.